ID   SK/IFN-gamma
AC   CVCL_B7TE
DR   cancercelllines; CVCL_B7TE
DR   Wikidata; Q112930406
RX   PubMed=15150552;
CC   Population: Caucasian.
CC   Characteristics: Intermediate type (I-type) (from parent cell line).
CC   Characteristics: MYCN-amplified NBL cell line (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0529 ! SK-N-BE(2)-C
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
RX   PubMed=15150552; DOI=10.1038/sj.bjc.6601842; PMCID=PMC2409504;
RA   Airoldi I., Meazza R., Croce M., Di Carlo E., Piazza T., Cocco C.,
RA   D'Antuono T., Pistoia V., Ferrini S., Corrias M.V.;
RT   "Low-dose interferon-gamma-producing human neuroblastoma cells show
RT   reduced proliferation and delayed tumorigenicity.";
RL   Br. J. Cancer 90:2210-2218(2004).
//